Renal failure
Conditions
Interventions
Hemodiafiltration using FS-311 for 2 weeks
Sponsors
Toray Industries,Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Renal failure patients under hemodiafitration or hemodialysis three times per week and 3 to 6 hours per session for more than a half year 2)Patients under hemodiafiltration for more than recent 2 weeks
Exclusion criteria
Exclusion criteria: 1)Patients who are pregnant or suspected to be pregnant, patients who are breast-feeding 2)Patients who are judged to be unable to attend this study as cardiovascular diseases by the investigator 3)Patients who have severe anemias or severe cardiovascular complications, patients who have severe arteriosclerosis obliterans 4)Patients with a history of allergy against extracorporeal circulation therapy 5)Other patients who are considerd ineligible for this study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)adverse events 2)Device deficiencies 3)blood compatibility(change of a white blood-cell count and platelets count during the HDF session) | — |
Countries
Japan
Contacts
Public ContactTakeshi Matsugi
Toray Industries,Inc. Medical Devices Clinical Research Dept.
Outcome results
None listed